Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Maria Dolores Santos-Rubio"'
Autor:
Maria Dolores Santos-Rubio, Paul Lebeau, D. Tran, Patricia Tarilonte, Pablo Mallaina, Lucía Galán, José Manuel Martínez-Sesmero, Francisco Muñoz-Beamud, Mark H. Rozenbaum, Michelle Stewart, Juan Gonzalez-Moreno, C. Peral
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 21(5)
Background: Transthyretin amyloid polyneuropathy (ATTR-PN) is a fatal disease associated with substantial burden of illness. Three therapies are approved by the European Medicines Agency for the management of this rare disease. The aim of this study
Autor:
Loreto Domínguez Senín, David Morales Pancorbo, María Yeray Rodríguez Garcés, María Dolores Santos-Rubio, Juan Bayo Calero
Publikováno v:
Current Oncology, Vol 31, Iss 1, Pp 250-259 (2024)
Objective: We aimed to evaluate the use of CDK4/6 inhibitors as a risk factor for medication-related osteonecrosis of the jaw (MRONJ) in a cohort of patients with metastatic breast cancer treated with denosumab. Methods: This was a multicentre, retro
Externí odkaz:
https://doaj.org/article/3c73cc0bf2b1469588603ae7d5ee3824
Autor:
Pilar Villar Santos, Maria Dolores Santos Rubio, Ana Peláez Bejarano, Maria de las Aguas Robustillo-Cortés, Ernesto Sánchez Gómez
Publikováno v:
European Journal of Hospital Pharmacy
Introduction During the COVID-19 pandemic, measures have been put in place to adapt to patients’ needs during home quarantine, such as “telehealthcare”. With this service, hospital pharmacists develop a distinct role via the implementation of p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.